FARYDAK (PANOBINOSTAT) CAPSULES

FARYDAK® (panobinostat) capsules, a histone deacetylase inhibitor, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent.

FARYDAK (Panobinostat) Capsules suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

ALLEVIARE LIFE SCIENCES connects the buyer with the supplier who can ship FARYDAK (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. FARYDAK is manufactured by Novartis Pharmaceuticals Corporation.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for FARYDAK (Panobinostat) Capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

FARYDAK panobinostat is a prescription medicine used, in combination with bortezomib and dexamethasone, to treat people with a type of cancer called multiple myeloma after at least 2 other types of treatment have been tried.

Medicine Name: FARYDAK
Generic Name: panobinostat
Approval Date: February 23, 2015
Available as (Form & Strength): 10 mg, 15 mg, and 20 mg Capsule for Oral Use
Company Name: Novartis Pharmaceuticals Corporation